408 related articles for article (PubMed ID: 17719014)
1. The role of orbitofrontal cortex in drug addiction: a review of preclinical studies.
Schoenbaum G; Shaham Y
Biol Psychiatry; 2008 Feb; 63(3):256-62. PubMed ID: 17719014
[TBL] [Abstract][Full Text] [Related]
2. [Orbitofrontal cortex in the genesis of in drug addiction].
Polunina AG; Briun EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(1):102-9. PubMed ID: 21434474
[No Abstract] [Full Text] [Related]
3. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex.
Volkow ND; Fowler JS
Cereb Cortex; 2000 Mar; 10(3):318-25. PubMed ID: 10731226
[TBL] [Abstract][Full Text] [Related]
4. Substance use disorders and the orbitofrontal cortex: systematic review of behavioural decision-making and neuroimaging studies.
Dom G; Sabbe B; Hulstijn W; van den Brink W
Br J Psychiatry; 2005 Sep; 187():209-20. PubMed ID: 16135857
[TBL] [Abstract][Full Text] [Related]
5. The orbital prefrontal cortex and drug addiction in laboratory animals and humans.
Everitt BJ; Hutcheson DM; Ersche KD; Pelloux Y; Dalley JW; Robbins TW
Ann N Y Acad Sci; 2007 Dec; 1121():576-97. PubMed ID: 17846151
[TBL] [Abstract][Full Text] [Related]
6. Thinking Outside the Box: Orbitofrontal Cortex, Imagination, and How We Can Treat Addiction.
Schoenbaum G; Chang CY; Lucantonio F; Takahashi YK
Neuropsychopharmacology; 2016 Dec; 41(13):2966-2976. PubMed ID: 27510424
[TBL] [Abstract][Full Text] [Related]
7. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals.
Tanabe J; Tregellas JR; Dalwani M; Thompson L; Owens E; Crowley T; Banich M
Biol Psychiatry; 2009 Jan; 65(2):160-4. PubMed ID: 18801475
[TBL] [Abstract][Full Text] [Related]
8. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.
Volkow ND; Chang L; Wang GJ; Fowler JS; Ding YS; Sedler M; Logan J; Franceschi D; Gatley J; Hitzemann R; Gifford A; Wong C; Pappas N
Am J Psychiatry; 2001 Dec; 158(12):2015-21. PubMed ID: 11729018
[TBL] [Abstract][Full Text] [Related]
9. Early orbitofrontal hyperactivation in obsessive-compulsive disorder.
Lagemann T; Rentzsch J; Montag C; Gallinat J; Jockers-Scherübl M; Winter C; Reischies FM
Psychiatry Res; 2012 Jun; 202(3):257-63. PubMed ID: 22809741
[TBL] [Abstract][Full Text] [Related]
10. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.
Goldstein RZ; Volkow ND
Am J Psychiatry; 2002 Oct; 159(10):1642-52. PubMed ID: 12359667
[TBL] [Abstract][Full Text] [Related]
11. Abnormally high degree connectivity of the orbitofrontal cortex in obsessive-compulsive disorder.
Beucke JC; Sepulcre J; Talukdar T; Linnman C; Zschenderlein K; Endrass T; Kaufmann C; Kathmann N
JAMA Psychiatry; 2013 Jun; 70(6):619-29. PubMed ID: 23740050
[TBL] [Abstract][Full Text] [Related]
12. Gene x disease interaction on orbitofrontal gray matter in cocaine addiction.
Alia-Klein N; Parvaz MA; Woicik PA; Konova AB; Maloney T; Shumay E; Wang R; Telang F; Biegon A; Wang GJ; Fowler JS; Tomasi D; Volkow ND; Goldstein RZ
Arch Gen Psychiatry; 2011 Mar; 68(3):283-94. PubMed ID: 21383264
[TBL] [Abstract][Full Text] [Related]
13. Orbitofrontal cortex and human drug abuse: functional imaging.
London ED; Ernst M; Grant S; Bonson K; Weinstein A
Cereb Cortex; 2000 Mar; 10(3):334-42. PubMed ID: 10731228
[TBL] [Abstract][Full Text] [Related]
14. Effects of varenicline on smoking cue–triggered neural and craving responses.
Franklin T; Wang Z; Suh JJ; Hazan R; Cruz J; Li Y; Goldman M; Detre JA; O'Brien CP; Childress AR
Arch Gen Psychiatry; 2011 May; 68(5):516-26. PubMed ID: 21199958
[TBL] [Abstract][Full Text] [Related]
15. Disentangling structural brain alterations associated with violent behavior from those associated with substance use disorders.
Schiffer B; Müller BW; Scherbaum N; Hodgins S; Forsting M; Wiltfang J; Gizewski ER; Leygraf N
Arch Gen Psychiatry; 2011 Oct; 68(10):1039-49. PubMed ID: 21646569
[TBL] [Abstract][Full Text] [Related]
16. Orbitofrontal cortex and cognitive-motivational impairments in psychostimulant addiction: evidence from experiments in the non-human primate.
Olausson P; Jentsch JD; Krueger DD; Tronson NC; Nairn AC; Taylor JR
Ann N Y Acad Sci; 2007 Dec; 1121():610-38. PubMed ID: 17698993
[TBL] [Abstract][Full Text] [Related]
17. Neural correlates of inflexible behavior in the orbitofrontal-amygdalar circuit after cocaine exposure.
Stalnaker TA; Roesch MR; Calu DJ; Burke KA; Singh T; Schoenbaum G
Ann N Y Acad Sci; 2007 Dec; 1121():598-609. PubMed ID: 17846156
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal from cocaine self-administration produces long-lasting deficits in orbitofrontal-dependent reversal learning in rats.
Calu DJ; Stalnaker TA; Franz TM; Singh T; Shaham Y; Schoenbaum G
Learn Mem; 2007 May; 14(5):325-8. PubMed ID: 17522022
[TBL] [Abstract][Full Text] [Related]
19. The role of the orbitofrontal cortex in normally developing compulsive-like behaviors and obsessive-compulsive disorder.
Evans DW; Lewis MD; Iobst E
Brain Cogn; 2004 Jun; 55(1):220-34. PubMed ID: 15134855
[TBL] [Abstract][Full Text] [Related]
20. The involvement of the orbitofrontal cortex in psychiatric disorders: an update of neuroimaging findings.
Jackowski AP; Araújo Filho GM; Almeida AG; Araújo CM; Reis M; Nery F; Batista IR; Silva I; Lacerda AL
Braz J Psychiatry; 2012 Jun; 34(2):207-12. PubMed ID: 22729418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
